Xavier Suárez‐Calvet

1.9k total citations
28 papers, 891 citations indexed

About

Xavier Suárez‐Calvet is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Xavier Suárez‐Calvet has authored 28 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Genetics. Recurrent topics in Xavier Suárez‐Calvet's work include Muscle Physiology and Disorders (14 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Myasthenia Gravis and Thymoma (4 papers). Xavier Suárez‐Calvet is often cited by papers focused on Muscle Physiology and Disorders (14 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Myasthenia Gravis and Thymoma (4 papers). Xavier Suárez‐Calvet collaborates with scholars based in Spain, United Kingdom and United States. Xavier Suárez‐Calvet's co-authors include Eduard Gallardo, Isabel Illa, Jordi Díaz‐Manera, Luís Querol, Ricard Rojas‐García, Eugenia Martínez‐Hernández, Miquel Navas‐Madroñal, Gisela Nogales‐Gadea, Noemí de Luna and C. Juárez and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Xavier Suárez‐Calvet

25 papers receiving 879 citations

Peers

Countries citing papers authored by Xavier Suárez‐Calvet

Since Specialization

Citations

This map shows the geographic impact of Xavier Suárez‐Calvet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Suárez‐Calvet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Suárez‐Calvet more than expected).

Fields of papers citing papers by Xavier Suárez‐Calvet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Suárez‐Calvet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Suárez‐Calvet. The network helps show where Xavier Suárez‐Calvet may publish in the future.

Co-authorship network of co-authors of Xavier Suárez‐Calvet

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Suárez‐Calvet. A scholar is included among the top collaborators of Xavier Suárez‐Calvet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Suárez‐Calvet. Xavier Suárez‐Calvet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy 2025 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Xavier Suárez‐Calvet, (unknown), Dan Cox, (unknown), (unknown), (unknown), Andrew Bowey, Paul R. P. Rushton, Susana López‐Fernández, Jordi Díaz‐Manera, (unknown)	1
2	Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy 2024 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), (unknown), (unknown), Jorge Alonso‐Pérez, (unknown), A. Nascimento, Giorgio Tasca, Rachel Queen, Dan Cox, Xavier Suárez‐Calvet, Jordi Díaz‐Manera	3
3	Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis 2023 ·Neurology Neuroimmunology & Neuroinflammation ·Rodrigo Álvarez‐Velasco, Oriol Dols‐Icardo, (unknown), Laura López-Vilaró, (unknown), David Reyes‐Leiva, Xavier Suárez‐Calvet, Elena Cortés‐Vicente, Isabel Illa, Eduard Gallardo	4
4	Colorimetric fusion of attenuation and birefringence in OCT signatures: a screening tool for evaluating muscular degradation in alpha-sarcoglican deficit murine models 2023 ·UCrea (University of Cantabria) ·(unknown), (unknown), (unknown), Xavier Suárez‐Calvet, José Miguel López Higuera, Jordi Díaz‐Manera, Olga M. Conde	1
5	Wide-field optical properties estimation of whole limbs in muscle dystrophy murine models via SFDI: a case study 2023 ·UCrea (University of Cantabria) ·(unknown), (unknown), (unknown), Xavier Suárez‐Calvet, José Miguel López Higuera, Jordi Díaz‐Manera, Olga M. Conde	0
6	BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients 2022 ·American Journal Of Pathology ·(unknown), (unknown), Xavier Suárez‐Calvet, (unknown), Jorge Alonso‐Pérez, Noemí de Luna, Benedikt Schoser, Peter Meinke, Cristina Domínguez‐González, Aurelio Hernández‐Laín, Carmen Paradas, Eloy Rivas, Isabel Illa, Montse Olivé, Eduard Gallardo, Jordi Díaz‐Manera	4
7	RhoA/ROCK2 signalling is enhanced by PDGF‐AA in fibro‐adipogenic progenitor cells: implications for Duchenne muscular dystrophy 2022 ·Journal of Cachexia Sarcopenia and Muscle ·(unknown), Xavier Suárez‐Calvet, (unknown), (unknown), Susana López‐Fernández, Gemma Pons, Joan Josep Bech‐Serra, Carolina de la Torre, Noemí de Luna, Eduard Gallardo, Jordi Díaz‐Manera	20
8	Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis 2020 ·Neurology Neuroimmunology & Neuroinflammation ·Xavier Suárez‐Calvet, Jorge Alonso‐Pérez, I. Castellví, (unknown), (unknown), Carlos Zamora, Laura Martínez‐Martínez, Alicia Alonso‐Jiménez, Ricardo Rojas‐García, (unknown), Luís Querol, Noemí de Luna, (unknown), Hèctor Corominas, Diego Castillo, Elena Cortés‐Vicente, Isabel Illa, Eduard Gallardo, Jordi Díaz‐Manera	15
9	Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes 2020 ·BMC Musculoskeletal Disorders ·(unknown), Cinta Lleixà, Xavier Suárez‐Calvet, Jordi Díaz‐Manera, Isabel Illa, Eduard Gallardo, Noemí de Luna	3
10	Identification of serum microRNAs as potential biomarkers in Pompe disease 2019 ·Annals of Clinical and Translational Neurology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Rosselló, Sonia Segovia, Noemí de Luna, Xavier Suárez‐Calvet, Isabel Illa, (unknown), Jordi Díaz‐Manera, Eduard Gallardo	21
11	Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy 2018 ·Cell Death and Disease ·(unknown), Xavier Suárez‐Calvet, (unknown), Eduard Gallardo, Natàlia de la Oliva, Anna Martínez‐Muriana, Pedro Gómez‐Gálvez, Luis M. Escudero, (unknown), Lutz Wollin, Noemí de Luna, Xavier Navarro, Isabel Illa, Jordi Díaz‐Manera	33
12	Platelet-Derived Growth Factor BB Influences Muscle Regeneration in Duchenne Muscle Dystrophy 2017 ·American Journal Of Pathology ·(unknown), Eduard Gallardo, Noemí de Luna, Xavier Suárez‐Calvet, (unknown), (unknown), (unknown), Isabel Illa, Jordi Díaz‐Manera	31
13	RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis 2017 ·Arthritis Research & Therapy ·Xavier Suárez‐Calvet, Eduard Gallardo, Iago Pinal‐Fernandez, Noemí de Luna, Cinta Lleixà, Jordi Díaz‐Manera, Ricardo Rojas‐García, I. Castellví, María Ángeles Martínez, Josep M. Grau, Albert Selva-O’Callaghan, Isabel Illa	32
14	Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis 2017 ·Scientific Reports ·Noemí de Luna, Xavier Suárez‐Calvet, Cinta Lleixà, Jordi Díaz‐Manera, Montse Olivé, Isabel Illa, Eduard Gallardo	30
15	The pathogenesis of dermatomyositis associated to MDA5 autoantibodies: An in vitro and in vivo study 2016 ·Neuromuscular Disorders ·Xavier Suárez‐Calvet, S. Toquet, Claire Danel, Anne Couvelard, (unknown), Y. Uzunhan, Eva Balada, Albert Selva-O’Callaghan, Yves Allenbach, Olivier Benvéniste	0
16	Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients 2014 ·PLoS ONE ·Gisela Nogales‐Gadea, Alba Ramos‐Fransí, Xavier Suárez‐Calvet, Miquel Navas‐Madroñal, Ricard Rojas‐García, José Luis Mosquera, Jordi Díaz‐Manera, Luís Querol, Eduard Gallardo, Isabel Illa	41
17	Bone Marrow Transplantation in Dysferlin-Deficient Mice Results in a Mild Functional Improvement 2013 ·Stem Cells and Development ·(unknown), Xavier Suárez‐Calvet, Jordi Díaz‐Manera, Eva Santos-Nogueira, Renzo Mancuso, Jordi Barquinero, Miquel Navas‐Madroñal, Xavier Navarro, Isabel Illa, Eduard Gallardo	6
18	Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy 2012 ·Annals of Neurology ·Luís Querol, Gisela Nogales‐Gadea, Ricard Rojas‐García, Eugenia Martínez‐Hernández, Jordi Díaz‐Manera, Xavier Suárez‐Calvet, Miquel Navas‐Madroñal, (unknown), Eduard Gallardo, Isabel Illa	262
19	Long-lasting treatment effect of rituximab in MuSK myasthenia 2012 ·Neurology ·Jordi Díaz‐Manera, Eugenia Martínez‐Hernández, Luís Querol, Rinse Klooster, Ricard Rojas‐García, Xavier Suárez‐Calvet, José Luís Muñoz-Blanco, Claudio Mazia, Kirsten R. Straasheijm, Eduard Gallardo, C. Juárez, Jan J.G.M. Verschuuren, Isabel Illa	233
20	Role of Thrombospondin 1 in Macrophage Inflammation in Dysferlin Myopathy 2010 ·Journal of Neuropathology & Experimental Neurology ·Noemí de Luna, Eduard Gallardo, Corinne Sonnet, Bénédicte Chazaud, Raúl Domínguez‐Perles, Xavier Suárez‐Calvet, Romain K. Gherardi, Isabel Illa	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact